HealthcareEconomy
China's Drug Approvals Surpass 2025 Total in H1 2026
China approved 11 domestically developed new-target drugs in H1 2026, exceeding 2025's total, with world-first therapies and record out-licensing deals.
—4 min read
Tag
1 article
China approved 11 domestically developed new-target drugs in H1 2026, exceeding 2025's total, with world-first therapies and record out-licensing deals.